Fixed on ESG
Assessing the Risk of Antimicrobial Resistance
February 3, 2026
This episode of Fixed on ESG explores what antimicrobial resistance is, why it matters, and its wide-ranging impact on health systems and the global economy.
Read More
keyboard_arrow_right